Skip to main content

300255 · 河北常山生化药业股份有限公司 · Debt

21.8900 CNY -1.0500 (-4.58%) At close · Oct 8
Market Cap
21.08B CNY
Shares
919.06M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Lease liabilities 2026-06-30 CNY 727,201 Interim report filed 2026-08-26
Long-term borrowings 2026-06-30 CNY 814,700,951 Interim report filed 2026-08-26
Short-term borrowings 2026-06-30 CNY 1,700,358,140 Interim report filed 2026-08-26
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.